4//SEC Filing
Sullivan Thomas Joseph 4
Accession 0000878526-22-000090
CIK 0000878526other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:12 PM ET
Size
7.3 KB
Accession
0000878526-22-000090
Insider Transaction Report
Form 4
Sullivan Thomas Joseph
Director
Transactions
- Disposition to Issuer
Common Stock, $0.001 par value per share
2022-07-21$33.50/sh−720,903$24,150,251→ 0 total - Award
Common Stock, $0.001 par value per share
2022-07-21+648,554→ 720,903 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock subject to performance-based stock unit awards ("RSUs") that vested and were settled as a result of the merger ("Merger") pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc. ("Parent"), Prince Mergerco Inc, and Issuer ("Merger Agreement"). Pursuant to, and subject to the terms of a retention agreement, dated April 17, 2022, between Mr. Sullivan, Parent and Issuer, $6,000,000 of the amount payable to Mr. Sullivan in respect of the RSUs did not become payable upon the Merger and, instead will become payable 50% on the six-month anniversary of the Merger and 50% on the one-year anniversary of the Merger ("Retention Holdback").
- [F2]Disposed of as a result of the Merger (subject to the Retention Holdback).
- [F3]Each share of Common Stock, including shares underlying equity awards, was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement (in the case of Mr. Sullivan, subject to the Retention Holdback), subject to applicable tax withholding.
Documents
Issuer
NATUS MEDICAL INC
CIK 0000878526
Entity typeother
Related Parties
1- filerCIK 0001510098
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 5:12 PM ET
- Size
- 7.3 KB